glp-1 shed Expert Panel: The Complete Journey Shed GLP-1 Review: Clinical Evidence

"No one loses 100% of their weight

Semaglutide with methylcobalamin has shown particular promise for addressing the B12 depletion that can occur during extended GLP-1 use

95% CI, 0.630.85), with no significant interaction by sex ( Regarding safety, women experienced a higher incidence of genital infections while on SGLT-2 inhibitors, likely due to anatomical predisposition, which may impact treatment adherence ( For GLP-1 receptor agonists, the REWIND trial demonstrated a reduction in cardiovascular events with dulaglutide, with a trend toward greater benefit in women, although statistical significance was not achieved (RR 0.85

Pancreatic islet alpha cells release factors, like glucagon, that stimulate beta cell function and increase glucose-dependent insulin secretion [76]